. Author manuscript; available in PMC: 2019 Dec 1.

Published in final edited form as: Diabetologia. 2018 Aug 29;61(12):2570–2579. doi: 10.1007/s00125-018-4720-1

Table 2.

Associations between lipids, adiponectin and ceramides

Ceramides	Total cholesterol	LDL-cholesterol	HDL-cholesterol	Triacylglycerol	Adiponectin
C16:0	0.44 (0.39, 0.49) ^†	0.42 (0.37, 0.46) ^†	−0.22 (−0.27, −0.17) ^†	0.33 (0.28, 0.38) ^†	−0.13 (−0.18, −0.07) ^†
C18:0	0.35 (0.30, 0.40) ^†	0.32 (0.27, 0.37) ^†	−0.20 (−0.26, −0.15) ^†	0.33 (0.28, 0.38) ^†	−0.21 (−0.27, −0.16) ^†
C20:0	0.31 (0.26, 0.36) ^†	0.30 (0.25, 0.34) ^†	−0.11 (−0.16, −0.06) ^†	0.21 (0.16, 0.26) ^†	−0.07 (−0.12, −0.02)^*
C22:1	0.28 (0.23, 0.33) ^†	0.32 (0.27, 0.37) ^†	−0.20 (−0.25, −0.15) ^†	0.13 (0.08, 0.18) ^†	−0.09 (−0.15, −0.04)^***
C22:9	0.45 (0.41, 0.50) ^†	0.51 (0.46, 0.55) ^†	−0.03 (−0.08, 0.02)	−0.04 (−0.09, 0.02)	−0.02 (−0.08, 0.03)
C22:10	0.42 (0.37, 0.46) ^†	0.40 (0.36, 0.45) ^†	−0.01 (−0.06, 0.04)	0.09 (0.04, 0.14)^***	−0.05 (−0.1, 0)
C24:2	0.24 (0.19, 0.29) ^†	0.28 (0.23, 0.33) ^†	−0.13 (−0.19, −0.08) ^†	0.07 (0.02, 0.12)^*	−0.04 (−0.1, 0.02)
C24:10	0.45 (0.40, 0.49) ^†	0.50 (0.46, 0.55) ^†	−0.04 (−0.09, 0.01)	−0.03 (−0.08, 0.02)	−0.03 (−0.09, 0.02)
C26:9	0.29 (0.25, 0.34) ^†	0.35 (0.31, 0.4) ^†	0.06 (0.01, 0.11)^*	−0.17 (−0.22, −0.12) ^†	0.04 (−0.01, 0.09)
C28:9	0.48 (0.44, 0.53) ^†	0.51 (0.46, 0.55)^†	−0.04 (−0.09, 0.01)	0.04 (−0.01, 0.1)	−0.07 (−0.12, −0.01)^*
C30:9	0.47 (0.42, 0.52) ^†	0.51 (0.47, 0.55) ^†	−0.02 (−0.07, 0.04)	−0.01 (−0.06, 0.04)	0 (−0.06, 0.05)
C30:10	0.43 (0.39, 0.48) ^†	0.50 (0.46, 0.55) ^†	−0.01 (−0.06, 0.04)	−0.11 (−0.16, −0.06) ^†	0 (−0.05, 0.06)
C32:11	0.39 (0.34, 0.44) ^†	0.47 (0.43, 0.52) ^†	−0.02 (−0.07, 0.04)	−0.14 (−0.19, −0.09) ^†	0.01 (−0.05, 0.06)

Data represent the β coefficient and 95% CI of the association adjusted for age, sex and race/ethnicity

p<0.05

^***

p<0.001 and

^†

p<0.0003